Sandy Draper
Stock Analyst at Guggenheim
(4.53)
# 313
Out of 4,435 analysts
88
Total ratings
57.28%
Success rate
18.1%
Average return
Main Sectors:
25 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACCD Accolade | Maintains: Buy | $17 → $13 | $7.08 | +83.62% | 4 | May 8, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $453 → $464 | $386.34 | +20.10% | 10 | Apr 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $219.09 | - | 6 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $208.44 | - | 10 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $21.19 | +60.45% | 6 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $7.87 | +27.06% | 3 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $27.73 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.49 | +304.69% | 3 | Jun 16, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $271 → $263 | $324.82 | -19.03% | 7 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $6.30 | +376.19% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $81.68 | +15.08% | 6 | Dec 7, 2022 | |
| TDOC Teladoc Health | Upgrades: Neutral | n/a | $11.24 | - | 5 | Oct 24, 2022 | |
| PRVA Privia Health Group | Maintains: Buy | $36 → $51 | $17.37 | +193.61% | 2 | Aug 12, 2022 | |
| NTRA Natera | Maintains: Buy | n/a | $106.53 | - | 2 | May 25, 2021 | |
| VCYT Veracyte | Maintains: Buy | n/a | $20.75 | - | 2 | May 18, 2021 | |
| EXAS Exact Sciences | Maintains: Buy | n/a | $45.45 | - | 2 | May 12, 2021 | |
| HIMS Hims & Hers Health | Initiates: Hold | n/a | $19.42 | - | 1 | Apr 21, 2021 | |
| AWH Aspira Women's Health | Initiates: Buy | n/a | $2.47 | - | 1 | Mar 29, 2021 | |
| PINC Premier | Maintains: Hold | n/a | $18.92 | - | 3 | Feb 4, 2021 | |
| PSNL Personalis | Initiates: Buy | n/a | $1.30 | - | 1 | Jan 28, 2021 | |
| NEO NeoGenomics | Initiates: Buy | n/a | $13.71 | - | 1 | Jan 28, 2021 | |
| HCAT Health Catalyst | Maintains: Buy | n/a | $6.63 | - | 2 | Apr 22, 2020 | |
| VEEV Veeva Systems | Maintains: Buy | n/a | $174.25 | - | 2 | Mar 26, 2020 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $9.50 | - | 1 | Jan 16, 2018 | |
| INCR InterCure | Upgrades: Buy | n/a | $2.95 | - | 2 | May 31, 2017 |
Accolade
May 8, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $7.08
Upside: +83.62%
Medpace Holdings
Apr 24, 2024
Maintains: Buy
Price Target: $453 → $464
Current: $386.34
Upside: +20.10%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $219.09
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $208.44
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $21.19
Upside: +60.45%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $7.87
Upside: +27.06%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $27.73
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.49
Upside: +304.69%
ICON PLC
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $324.82
Upside: -19.03%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $6.30
Upside: +376.19%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $81.68
Upside: +15.08%
Teladoc Health
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $11.24
Upside: -
Privia Health Group
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $17.37
Upside: +193.61%
Natera
May 25, 2021
Maintains: Buy
Price Target: n/a
Current: $106.53
Upside: -
Veracyte
May 18, 2021
Maintains: Buy
Price Target: n/a
Current: $20.75
Upside: -
Exact Sciences
May 12, 2021
Maintains: Buy
Price Target: n/a
Current: $45.45
Upside: -
Hims & Hers Health
Apr 21, 2021
Initiates: Hold
Price Target: n/a
Current: $19.42
Upside: -
Aspira Women's Health
Mar 29, 2021
Initiates: Buy
Price Target: n/a
Current: $2.47
Upside: -
Premier
Feb 4, 2021
Maintains: Hold
Price Target: n/a
Current: $18.92
Upside: -
Personalis
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $1.30
Upside: -
NeoGenomics
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $13.71
Upside: -
Health Catalyst
Apr 22, 2020
Maintains: Buy
Price Target: n/a
Current: $6.63
Upside: -
Veeva Systems
Mar 26, 2020
Maintains: Buy
Price Target: n/a
Current: $174.25
Upside: -
Veradigm
Jan 16, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.50
Upside: -
InterCure
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $2.95
Upside: -